Flagship Harbor Advisors, LLC Nektar Therapeutics Transaction History

Flagship Harbor Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	BUY	$0.64 - $3.15 $6,752 - $33,232	10,550 New	10,550 $7,000
Q4 2020 Feb 08, 2021	SELL	$15.77 - $19.03 $111,493 - $134,542	-7,070 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$14.47 - $27.96 $37,983 - $73,395	2,625 Added 59.06%	7,070 $126,000
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $32,216 - $46,933	-2,030 Reduced 31.35%	4,445 $96,000
Q2 2019 Jul 22, 2019	BUY	$31.0 - $36.3 $26,908 - $31,508	868 Added 15.48%	6,475 $230,000
Q1 2019 Apr 15, 2019	BUY	$31.58 - $46.35 $26,369 - $38,702	835 Added 17.5%	5,607 $188,000
Q4 2018 Jan 28, 2019	BUY	$30.43 - $56.65 $17,953 - $33,423	590 Added 14.11%	4,772 $156,000
Q3 2018 Nov 05, 2018	BUY	$46.46 - $68.49 $58,957 - $86,913	1,269 Added 43.56%	4,182 $237,000
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $134,726 - $304,262	2,913 New	2,913 $142,000

153

131M

92.7K

4.9K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $154M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.